Cramer: Are high-reward biotech bargains worth it? By: CNBC.com News September 02, 2015 at 18:25 PM EDT Jim Cramer takes a look at speculative biotechs to find out if the bargains are worth the reward in your portfolio. Read More >> Related Stocks: JPMorgan Chase & Co